FATE
Fate Therapeutics Inc
2.30$
+0.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 663.2% | 606.6% | 775.7% | 772.6% | 836.1% | 962.7% | 1,118.5% | 1,637.4% | 1,329.1% | 848.6% | 673.6% | 767.9% | 955.2% | 899.7% | 1,164.1% | 488.0% | 406.1% | 245.2% | 402.5% | 358.1% | 373.5% | 407.3% | 391.8% | 438.3% | 532.8% | 196.6% | 111.3% | 4,381.1% | 243.8% | 291.5% | 250.4% | 69.7% | 1,127.2% | 921.5% | 1,788.6% | 200.4% | 1,484.1% | 223.7% | 224.6% | – | – | |
| -563.2% | -506.6% | -675.7% | -672.6% | -736.1% | -862.7% | -1,018.5% | -1,537.4% | -1,229.1% | -748.6% | -573.6% | -667.9% | -855.2% | 100.0% | -1,064.1% | -388.0% | -306.1% | -145.2% | -302.5% | -258.1% | -273.5% | -307.3% | -291.8% | -338.3% | -432.8% | -96.6% | -11.3% | -4,281.1% | -143.8% | -191.5% | -150.4% | 30.3% | -1,027.2% | -821.5% | -1,688.6% | -100.4% | -1,384.1% | 100.0% | -124.6% | 100.0% | -343.0% | |
| 663.2% | 606.6% | 775.7% | 772.6% | 836.1% | 962.7% | 1,118.5% | 1,637.4% | 1,329.1% | 848.6% | 673.6% | 767.9% | 955.2% | 899.7% | 1,164.1% | 488.0% | 406.1% | 245.2% | 402.5% | 358.1% | 373.5% | 407.3% | 391.8% | 438.3% | 532.8% | 196.6% | 111.3% | 4,381.1% | 1,763.1% | 1,898.3% | 1,669.5% | 511.0% | 1,127.2% | 1,806.9% | 1,788.6% | 1,438.4% | 1,484.1% | 1,857.2% | 1,677.1% | 1,171.3% | 1,501.1% | |
| 254.5% | 238.7% | 295.2% | 260.1% | 271.7% | 329.5% | 351.3% | 371.6% | 397.8% | 259.3% | 203.3% | 187.1% | 261.3% | 238.1% | 307.3% | 137.3% | 110.5% | 64.9% | 112.2% | 90.7% | 110.5% | 99.2% | 112.6% | 109.7% | 143.9% | 48.7% | 37.2% | 2,424.7% | 974.7% | 1,070.1% | 1,083.4% | 254.7% | 676.7% | 820.5% | 845.5% | 600.2% | 611.0% | 779.0% | 738.7% | 424.1% | 612.0% | |
| 917.6% | 845.3% | 1,070.9% | 1,032.7% | 1,107.8% | 1,292.2% | 1,469.8% | 2,009.0% | 1,726.9% | 1,107.9% | 876.8% | 955.0% | 1,216.5% | 1,137.8% | 307.3% | 137.3% | 110.5% | 64.9% | 112.2% | 90.7% | 110.5% | 99.2% | 112.6% | 109.7% | 143.9% | 48.7% | 37.2% | 2,424.7% | 2,494.0% | 2,677.0% | 2,502.4% | 696.0% | 676.7% | 2,498.3% | 845.5% | 1,838.2% | 611.0% | 2,636.2% | 2,415.8% | 1,595.4% | 1,715.1% | |
| -817.6% | -745.3% | -970.9% | -932.7% | -1,007.8% | -1,192.2% | -1,369.8% | -1,909.0% | -1,626.9% | -1,007.9% | -776.8% | -855.0% | -1,116.5% | -1,037.8% | -1,371.5% | -525.3% | -416.6% | -210.1% | -414.7% | -348.8% | -384.0% | -406.5% | -404.4% | -448.1% | -576.7% | -145.2% | -48.5% | -6,705.8% | -2,637.8% | -2,868.4% | -2,652.9% | -665.7% | -1,703.9% | -3,319.8% | -2,534.1% | -1,938.5% | -1,995.1% | -2,536.2% | -2,540.4% | -1,495.4% | -2,058.1% | |
| 37.5% | 32.0% | 25.9% | 20.7% | 36.8% | 40.1% | 40.2% | 41.4% | 41.8% | 25.9% | 15.4% | 14.5% | 16.5% | 19.2% | 38.6% | 11.6% | 5.9% | 2.2% | 3.4% | 2.6% | 2.0% | 1.7% | 2.3% | 4.1% | 11.9% | 6.5% | 16.5% | – | – | 579.4% | – | – | – | – | – | – | – | – | – | – | – | |
| -851.6% | -773.1% | -986.0% | -940.1% | -1,041.3% | -1,216.8% | -1,377.7% | -1,913.7% | -1,635.7% | -964.9% | -750.8% | -833.4% | -1,095.5% | -1,010.1% | -1,332.8% | -513.7% | -776.4% | -334.1% | -404.7% | -411.1% | -304.4% | -402.0% | -356.7% | -410.3% | -557.8% | -127.1% | -32.0% | -5,654.3% | -2,323.6% | -2,632.6% | -2,493.7% | -567.4% | -1,551.0% | -2,803.9% | -2,309.5% | -1,786.6% | -1,852.4% | -2,364.8% | -2,402.8% | -1,448.6% | -1,941.1% | |
| 3.6% | -15.6% | 10.8% | 13.4% | 36.8% | -12.8% | 32.3% | 36.6% | 33.0% | 49.2% | 41.5% | 36.0% | 37.5% | 24.7% | – | 11.6% | – | -5.4% | -10.1% | 62.3% | -79.5% | -12.9% | -47.7% | -4.1% | -18.9% | -18.2% | -16.5% | -469.6% | -243.8% | 1,123.6% | 248.2% | – | – | -256.9% | – | – | – | – | – | – | – | |
| -851.6% | -773.1% | -986.0% | -940.1% | -1,041.3% | -1,216.8% | -1,377.7% | -1,913.7% | -1,635.7% | -964.9% | -750.8% | -833.4% | -1,095.5% | -1,010.1% | -1,332.8% | -513.7% | -776.4% | -334.1% | -404.7% | -411.1% | -304.4% | -402.0% | -356.7% | -410.3% | -557.8% | -127.1% | -32.0% | -5,654.3% | -2,323.6% | -2,632.6% | -2,493.7% | -567.4% | -1,551.0% | -2,803.9% | -2,309.5% | -1,786.6% | -1,852.4% | -2,364.8% | -2,402.8% | -1,448.6% | -1,941.1% | |
| -792.8% | -721.3% | -940.0% | -896.9% | -980.7% | -1,148.5% | -1,309.6% | -1,845.0% | -1,563.6% | -919.3% | -718.7% | -799.6% | -1,054.8% | -968.6% | -1,343.4% | -511.6% | -406.4% | -204.7% | -406.1% | -402.4% | -293.8% | -389.1% | -341.7% | -394.3% | -536.5% | -116.2% | -24.9% | -5,175.7% | -2,079.7% | -2,341.1% | -2,243.3% | -497.7% | -1,401.1% | -2,268.7% | -2,104.8% | -1,614.7% | -1,667.0% | -2,141.1% | -2,178.2% | -1,467.5% | -1,805.3% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.